Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America Mar 4, 2026 07:00AM
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened Mar 3, 2026 07:00AM
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 27, 2026 04:05PM
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Feb 19, 2026 04:05PM
Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open Feb 12, 2026 02:35PM
View Older Stories

Feb 3, 2026 04:05PM Guardant Health to Participate in Upcoming Investor Conferences
Feb 2, 2026 08:07AM Guardant Health blood test shows improved cancer recurrence prediction
Feb 2, 2026 08:05AM Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Trea
Jan 29, 2026 04:05PM Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Jan 22, 2026 08:05AM Guardant Health gets FDA approval for colorectal cancer test
Jan 22, 2026 08:05AM Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Jan 19, 2026 08:05AM Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
Jan 12, 2026 04:07AM Guardant Health posts 39% revenue growth in fourth quarter
Jan 11, 2026 05:00PM Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
Jan 8, 2026 08:05AM Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
Dec 29, 2025 04:05PM Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Dec 11, 2025 08:05AM Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
Dec 9, 2025 08:07AM Guardant Health launches liquid biopsy testing at Italian hospital
Dec 9, 2025 08:05AM Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
Dec 5, 2025 08:05AM Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San A
Nov 12, 2025 08:05AM Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access
Nov 10, 2025 08:05AM Guardant Health expands blood test for late-stage cancer monitoring
Nov 10, 2025 08:05AM Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
Nov 7, 2025 08:00AM Guardant Health to Participate in Upcoming Investor Conferences
Nov 6, 2025 06:35PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2025 08:05AM New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
Nov 5, 2025 04:05PM Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
Oct 29, 2025 04:05PM Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Oct 27, 2025 08:05AM Guardant Health partners with Zephyr AI for cancer biomarker research
Oct 27, 2025 08:05AM Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights
Oct 26, 2025 03:01PM Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
Oct 15, 2025 04:57PM Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025
Oct 9, 2025 04:05PM Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025
Sep 29, 2025 08:05AM FDA approves Guardant Health test for Eli Lilly breast cancer drug
Sep 29, 2025 08:05AM FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
Sep 24, 2025 08:05AM Guardant Health partners with Quest for blood-based cancer screening
Sep 24, 2025 08:05AM Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
Sep 15, 2025 04:07PM Former health secretary Alex Azar joins Guardant Health board
Sep 15, 2025 04:07PM Alex M. Azar II Joins Guardant Health Board of Directors
Sep 11, 2025 08:05AM Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
Sep 8, 2025 08:05AM Guardant Health partners with PathGroup to expand Shield blood test access
Sep 8, 2025 08:05AM Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
Sep 4, 2025 08:07AM Guardant Health reports improved Shield cancer test performance
Sep 4, 2025 08:06AM Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
Aug 28, 2025 04:05PM Guardant Health to Host Investor Day on September 24, 2025
Aug 26, 2025 04:05PM Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 15, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 4, 2025 08:06AM American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
Jul 31, 2025 04:05PM Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 30, 2025 04:05PM Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Jul 30, 2025 08:09AM Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Jul 29, 2025 08:07AM New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
Jul 15, 2025 11:01AM First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
Jul 14, 2025 08:00AM Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
Jun 10, 2025 07:05AM Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
View Older Stories